Global Information
회사소개 | 문의 | 위시리스트

세계의 체외진단(IVD) 시장 기회 분석과 산업 예측 : 제품별, 기술별, 용도별, 최종사용자별

In Vitro Diagnostics (IVD) Market by Product Type (Reagents, Instruments, and Software & Services), Technique, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

리서치사 Allied Market Research
발행일 2018년 12월 상품 코드 563263
페이지 정보 영문 377 Pages
가격
US $ 3,840 ₩ 4,547,000 PDF by E-mail (Data Pack) help
DRM(디지털 저작권 관리 시스템) 장착 Excel 파일로, 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 Excel파일 라이선스 소유자로 한정됩니다.
US $ 5,370 ₩ 6,359,000 PDF by E-mail (Single User License) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 6,450 ₩ 7,638,000 PDF by E-mail (5-user License) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,995 ₩ 10,652,000 PDF by E-mail (Enterprise User License)

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 체외진단(IVD) 시장 기회 분석과 산업 예측 : 제품별, 기술별, 용도별, 최종사용자별 In Vitro Diagnostics (IVD) Market by Product Type (Reagents, Instruments, and Software & Services), Technique, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025
발행일 : 2018년 12월 페이지 정보 : 영문 377 Pages

세계의 체외진단(IVD) 시장에 대해 조사했으며, 시장 동향과 제품별, 기술별, 용도별, 최종사용자별, 지역별 동향, 시장에 진출하는 주요 기업 개요 등의 정보를 전해드립니다.

제1장 서론

제2장 주요 요약

제3장 시장 개요

  • 시장 정의와 범위
  • 주요 조사 결과
  • Porter's Five Forces 분석
  • 시장 점유율 분석
  • 시장 동향
    • 성장 촉진요인
    • 성장 저해요인
    • 기회

제4장 제품 종류별 시장

  • 개요
  • 시약
  • 장비
  • 소프트웨어 및 서비스

제5장 기술별 시장

  • 개요
  • 면역진단
  • 혈액검사
  • 분자진단
  • 조직진단
  • 임상화학
  • 기타

제6장 용도별 시장

  • 감염증
  • 심장병
  • 면역계 질환
  • 신경 질환
  • 위장 질환
  • 기타

제7장 최종사용자별 시장

  • 독립형 시험기관
  • 병원
  • 학술 및 의과대학
  • Point of Care(POC) 검사
  • 기타

제8장 지역별 시장

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카

제9장 기업 개요

KSM 17.10.23

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

LIST OF TABLES

  • TABLE 01. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
  • TABLE 02. IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 20162023 ($MILLION)
  • TABLE 03. IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 20172025 ($MILLION)
  • TABLE 04. IN-VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 20172025 ($MILLION)
  • TABLE 05. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
  • TABLE 06. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY TYPE, 20172025 ($MILLION)
  • TABLE 07. IN-VITRO DIAGNOSTICS MARKET FOR ELISA, BY TYPE 20172025 ($MILLION)
  • TABLE 08. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
  • TABLE 09. IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION, 20172025 ($MILLION)
  • TABLE 10. MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 20172025 ($MILLION)
  • TABLE 11. IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
  • TABLE 12. IN-VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY REGION, 20172025 ($MILLION)
  • TABLE 13. CLINICAL CHEMISTRY MARKET, BY TYPE, 20172025 ($MILLION)
  • TABLE 14. IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 20172025 ($MILLION)
  • TABLE 15. IN-VITRO DIAGNOSTICS MARKET FOR OTHER IVD TECHNIQUES, BY REGION, 20172025 ($MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY INDICATION, 20172025 ($MILLION)
  • TABLE 17. IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION,20172025 ($MILLION)
  • TABLE 18. IN-VITRO DIAGNOSTICS MARKET FOR CANCER, BY REGION, 20172025 ($MILLION)
  • TABLE 19. IN-VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY REGION, 20172025 ($MILLION)
  • TABLE 20. IN-VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 20172025 ($MILLION)
  • TABLE 21. IN-VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 20172025 ($MILLION)
  • TABLE 22. IN-VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 20172025 ($MILLION)
  • TABLE 23. IN-VITRO DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY REGION, 20172025 ($MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 25. IN-VITRO DIAGNOSTICS MARKET FOR STAND-ALONE LABORATORY, BY REGION, 20172025 ($MILLION)
  • TABLE 26. IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 20172025 ($MILLION)
  • TABLE 27. IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY REGION, 20172025 ($MILLION)
  • TABLE 28. IN-VITRO DIAGNOSTICS MARKET FOR POINT OF CARE TESTING, BY REGION, 20172025 ($MILLION)
  • TABLE 29. IN-VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)
  • TABLE 30. IN-VITRO DIAGNOSTICS MARKET REVENUE, BY REGION, 20172025 ($MILLION)
  • TABLE 31. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 32. U.S. IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 33. U.S. IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 34. U.S. IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 35. U.S. IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 36. CANADA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 37. CANADA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 38. CANADA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 39. CANADA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 40. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 41. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 42. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 43. MEXICO IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 44. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
  • TABLE 45. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
  • TABLE 46. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 47. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 48. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 49. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 50. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 51. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 52. GERMANY IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 53. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 54. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 55. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 56. FRANCE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 57. UK IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 58. UK IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 59. UK IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 60. UK IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 61. ITALY IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 62. ITALY IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 63. ITALY IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 64. ITALY IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 65. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 66. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 67. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 68. SPAIN IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 69. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 70. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 71. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 72. REST OF EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 73. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
  • TABLE 74. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
  • TABLE 75. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 76. EUROPE IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 77. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 78. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 79. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 80. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 81. JAPAN IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 82. CHINA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 83. CHINA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 84. CHINA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 85. CHINA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 86. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 87. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 88. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 89. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 90. INDIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 91. INDIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 92. INDIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 93. INDIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 94. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 95. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 96. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 97. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 98. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 99. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 100. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 101. REST OF ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 102. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
  • TABLE 103. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
  • TABLE 104. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY INDICATION, 20172025 ($MILLION)
  • TABLE 105. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 106. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY COUNTRY, 20172025 ($MILLION)
  • TABLE 107. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 108. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 109. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 110. BRAZIL IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 111. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 112. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 113. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 114. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 115. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 116. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 117. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 118. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 119. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2017-2025
  • TABLE 120. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2017-2025
  • TABLE 121. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2017-2025
  • TABLE 122. REST OF LAMEA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 2017-2025
  • TABLE 123. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE, 20172025 ($MILLION)
  • TABLE 124. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 20172025 ($MILLION)
  • TABLE 125. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
  • TABLE 126. LAMEA IN-VITRO DIAGNOSTICS MARKET, BY END USER, 20172025 ($MILLION)
  • TABLE 127. ABBOTT: COMPANY SNAPSHOT
  • TABLE 128. ABBOTT: OPERATING SEGMENTS
  • TABLE 129. ABBOTT: PRODUCT TYPE PORTFOLIO
  • TABLE 130. BD : COMPANY SNAPSHOT
  • TABLE 131. BD : OPERATING SEGMENTS
  • TABLE 132. BD : PRODUCT TYPE PORTFOLIO
  • TABLE 133. BIOMRIEUX: COMPANY SNAPSHOT
  • TABLE 134. BIOMRIEUX: PRODUCT TYPE PORTFOLIO
  • TABLE 135. BIO-RAD: COMPANY SNAPSHOT
  • TABLE 136. BIO-RAD: OPERATING SEGMENTS
  • TABLE 137. BIO-RAD: PRODUCT TYPE PORTFOLIO
  • TABLE 138. DANAHER: COMPANY SNAPSHOT
  • TABLE 139. DANAHER: OPERATING SEGMENTS
  • TABLE 140. DANAHER: PRODUCT TYPE PORTFOLIO
  • TABLE 141. ROCHE: COMPANY SNAPSHOT
  • TABLE 142. ROCHE: OPERATING SEGMENTS
  • TABLE 143. ROCHE: PRODUCT TYPE PORTFOLIO
  • TABLE 144. J&J: COMPANY SNAPSHOT
  • TABLE 145. J&J: OPERATING SEGMENTS
  • TABLE 146. J&J: PRODUCT TYPE PORTFOLIO
  • TABLE 147. QIAGEN: COMPANY SNAPSHOT
  • TABLE 148. QIAGEN: PRODUCT TYPE PORTFOLIO
  • TABLE 149. SYSMEX: COMPANY SNAPSHOT
  • TABLE 150. SYSMEX: PRODUCT TYPE PORTFOLIO
  • TABLE 151. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 152. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 153. THERMO FISHER SCIENTIFIC: PRODUCT TYPE PORTFOLIO

List of Figures

LIST OF FIGURES

  • FIGURE 01. IN-VITRO DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 02. TOP INVESTMENT POCKETS
  • FIGURE 03. TOP WINNING STRATEGIES, 2015-2018
  • FIGURE 04. FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE, 2015-2018
  • FIGURE 05. TOP PLAYER POSITIONING, 2017
  • FIGURE 06. MODERATE BARGANING POWER OF BUYERS
  • FIGURE 07. HIGH BARGANING POWER OF SUPPLIERS
  • FIGURE 08. MODERATE THREAT OF SUBSTITUTION
  • FIGURE 09. LOW THREAT OF NEW ENTRANTS
  • FIGURE 10. HIGH COMPETITIVE RIVALRY
  • FIGURE 11. IMPACT ANALYSES, IN-VITRO DIAGNOSTICS MARKET
  • FIGURE 12. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY COUNTRY, 2017 & 2025
  • FIGURE 13. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2017 & 2025
  • FIGURE 14. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2017 & 2025
  • FIGURE 15. CHEMILUMINESCENCE IMMUNOASSAY (CLIA) MARKET, 20172025 ($MILLION)
  • FIGURE 16. FLUORESENCE IMMUNOASSAY (FIA) MARKET, 20172025 ($MILLION)
  • FIGURE 17. COLORIMETRIC IMMUNOASSAYS (CI) MARKET, 20172025 ($MILLION)
  • FIGURE 18. IMMUNO-DIAGNOSTICS MARKET FOR RAPID TESTS, 20172025 ($MILLION)
  • FIGURE 19. IMMUNO-DIAGNOSTICS MARKET FOR ENZYME-LINKED IMMUNOSPOT (ELISPOT), 20172025 ($MILLION)
  • FIGURE 20. IMMUNO-DIAGNOSTICS MARKET FOR RADIOIMMUNOASSAYS (RIA), 20172025 ($MILLION)
  • FIGURE 21. IMMUNO-DIAGNOSTICS MARKET FOR WESTERN BLOT, 20172025 ($MILLION)
  • FIGURE 22. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR IMMUNO-DIAGNOSTICS, BY COUNTRY, 2017 & 2025
  • FIGURE 23. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY, 2017 & 2025
  • FIGURE 24. MOLECULAR DIAGNOSTICS MARKET FOR POLYMERIZE CHAIN REACTION (PCR), 20172025 ($MILLION)
  • FIGURE 25. MOLECULAR DIAGNOSTICS MARKET FOR ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT), 20172025 ($MILLION)
  • FIGURE 26. MOLECULAR DIAGNOSTICS MARKET FOR HYBRIDIZATION, 20172025 ($MILLION)
  • FIGURE 27. MOLECULAR DIAGNOSTICS MARKET FOR DNA DIAGNOSTICS, 20172025 ($MILLION)
  • FIGURE 28. MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAY, 20172025 ($MILLION)
  • FIGURE 29. MOLECULAR DIAGNOSTICS MARKET FOR OTHERS, 20172025 ($MILLION)
  • FIGURE 30. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2017 & 2025
  • FIGURE 31. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY COUNTRY, 2017 & 2025
  • FIGURE 32. CLINICAL CHEMISTRY MARKET FOR BASIC METABOLIC PANEL, 20172025 ($MILLION)
  • FIGURE 33. CLINICAL CHEMISTRY MARKET FOR LIVER PANEL, 20172025 ($MILLION)
  • FIGURE 34. CLINICAL CHEMISTRY MARKET FOR RENAL PROFILE, 20172025 ($MILLION)
  • FIGURE 35. CLINICAL CHEMISTRY MARKET FOR LIPID PROFILE, 20172025 ($MILLION)
  • FIGURE 36. CLINICAL CHEMISTRY MARKET FOR THYROID FUNCTION PANEL, 20172025 ($MILLION)
  • FIGURE 37. CLINICAL CHEMISTRY MARKET FOR ELECTROLYTE PANEL, 20172025 ($MILLION)
  • FIGURE 38. CLINICAL CHEMISTRY MARKET FOR SPECIALTY CHEMICALS, 20172025 ($MILLION)
  • FIGURE 39. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2017 & 2025
  • FIGURE 40. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHER IVD TECHNIQUES, BY COUNTRY, 2017 & 2025
  • FIGURE 41. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2017 & 2025
  • FIGURE 42. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CANCER, BY COUNTRY, 2017 & 2025
  • FIGURE 43. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY COUNTRY, 2017 & 2025
  • FIGURE 44. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY COUNTRY, 2017 & 2025
  • FIGURE 45. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2017 & 2025
  • FIGURE 46. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2017 & 2025
  • FIGURE 47. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2017 & 2025
  • FIGURE 48. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR STAND-ALONE LABORATORY, BY COUNTRY, 2017 & 2025
  • FIGURE 49. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2017 & 2025
  • FIGURE 50. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY COUNTRY, 2017 & 2025
  • FIGURE 51. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR POINT OF CARE TESTING, BY COUNTRY, 2017 & 2025
  • FIGURE 52. COMPARATIVE ANALYSIS OF IN-VITRO DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025
  • FIGURE 53. EUROPEAN GERIATRIC POPULATION (ABOVE 65 YEARS), 2017
  • FIGURE 54. ABBOTT: NET SALES, 20152017 ($MILLION)
  • FIGURE 55. ABBOTT: NET SALES SHARE, BY OPERATING SEGMENT, 2017 (%)
  • FIGURE 56. ABBOTT: NET SALES SHARE, BY GEOGRAPHY, 2017 (%)
  • FIGURE 57. BD: REVENUE, 20152017 ($MILLION)
  • FIGURE 58. BD: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 59. BD: REVENUE SHARE BY REGION, 2017 (%)
  • FIGURE 60. BIOMRIEUX: NET SALES, 20152017 ($MILLION)
  • FIGURE 61. BIOMRIEUX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 62. BIO-RAD: NET SALES, 20152017 ($MILLION)
  • FIGURE 63. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 64. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 65. DANAHER: NET SALES, 20152017 ($MILLION)
  • FIGURE 66. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 67. DANAHER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 68. ROCHE: NET SALES, 20152017 ($MILLION)
  • FIGURE 69. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 70. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 71. J&J: REVENUE, 20152017 ($MILLION)
  • FIGURE 72. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 73. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 74. QIAGEN: NET SALES, 20152017 ($MILLION)
  • FIGURE 75. QIAGEN: REVENUE SHARE BY PRODUCT TYPE, 2017 (%)
  • FIGURE 76. QIAGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
  • FIGURE 77. SYSMEX: REVENUE, 20152017 ($MILLION)
  • FIGURE 78. SYSMEX: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
  • FIGURE 79. THERMO FISHER SCIENTIFIC: REVENUE, 20152017 ($MILLION)
  • FIGURE 80. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)
  • FIGURE 81. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

Title:
In Vitro Diagnostics (IVD) Market by Product Type (Reagents, Instruments, and Software & Services), Technique (Immunodiagnostics {Enzyme-Linked Immunosorbent Assay [Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FIA), and Colorimetric Immunoassay (CI)], Rapid Tests, Enzyme-Linked ImmunoSpot (ELISPOT), Radioimmunoassay (RIA), and Western Blot}, Hematology, Molecular Diagnostics {Polymerize Chain Reaction (PCR), Isothermal Nucleic Acid Technology (INAAT), Hybridization, DNA Diagnostics, Microarray, and Others}, Tissue Diagnostics, Clinical Chemistry {Basic Metabolic Panel, Liver Panel, Lipid Profile, Thyroid Function Panel, Electrolyte Panel, and Specialty Chemicals}, and Other IVD Techniques), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and End User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care Testing, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025 .

IVD Market Overview:

  • The global in vitro diagnostics (IVD) market was valued at $64,479 million in 2017, and is estimated to reach at $93,614 million by 2025, registering a CAGR of 4.8% from 2018 to 2025.
  • In vitro diagnostic (IVD) is a technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from the human body to detect diseases, conditions, and infections. The tests can be performed in stand-alone laboratory, hospital-based laboratory, and point of care. Some of the significant technologies incorporated in IVD include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product type design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.
  • Rise in need for IVD testing arises due to increase in incidences of chronic and infectious diseases and growth in geriatric population prone to immunological disorders. Moreover, advancements in personalized medicines and widespread knowledge of rare diseases are expected to boost the growth of the global IVD market. In addition, increase in incidences of colorectal cancer, neurological disorders, and gynecological diseases are anticipated to boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavorable reimbursement policies are expected to restrain the growth of the global market.
  • The report segments the market across different categories such as product type, technique, application, end users, and region. Based on product type, the market is segmented into reagents, instruments, and services & software.
  • Based on techniques, the market is segmented into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. The immunodiagnostics is further segmented into enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. The ELISA segment is further classified into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Molecular diagnostics segment is further divided into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarrays, and others. Similarly, clinical chemistry segment is categorized into basic metabolic panel, liver panel, lipid profile, thyroid function panel, renal profile, electrolyte panel, and specialty chemicals.

By application, the market is classified into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end user, it is divided into hospitals, academic & medical schools, point of care testing, and others. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

  • Key players profiled in the report include Abbott Laboratories; Becton, Dickinson and Company; bioMerieux SA, Bio-Rad Laboratories, Inc.; Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Johnson & Johnson; QIAGEN N.V.; Sysmex Corporation; and Thermo Fisher Scientific, Inc.

Key Benefits for IVD Market:

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

IVD Key Market Segments:

By Product Type

  • Reagents
  • Instruments
  • Software & Services

By Techniques

  • Immunodiagnostics
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassays (CLIAS)
  • Fluorescence Immunoassays (FIAS)
  • Colorimetric Immunoassays (CIS)
  • Rapid Tests
  • Enzyme-Linked ImmunoSpot Assays (ELISPOT)
  • Radioimmunoassay
  • Western Blot
  • Hematology
  • Molecular Diagnostics
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Hybridization
  • DNA Diagnostics
  • Microarrays
  • Others
  • Tissue Diagnostics
  • Clinical Chemistry
  • Basic Metabolic Panel
  • Liver Panel
  • Lipid Profile
  • Thyroid Function Panel
  • Renal Profile
  • Electrolyte Panel
  • Specialty Chemicals
  • Other IVD Techniques

By End User

  • Standalone Laboratory
  • Hospitals
  • Academic & Medical Schools
  • Point of Care Testing
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • List Of Key Players Profiled in the Report
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Beckman Coulter, Inc.)
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • QIAGEN N.V.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request)
  • Illumina, Inc.
  • Luminex Corporation.
  • Siemens Healthcare GmbH.

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
    • 1.3.1. List of key players profiled in the report
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. Key findings of the study
  • 2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top investment pockets
  • 3.3. Top winning strategies, 2017
  • 3.4. Top player positioning, 2017
  • 3.5. Porters five forces analysis
  • 3.6. Market dynamics
    • 3.6.1. Drivers
      • 3.6.1.1. Increase in incidence of chronic and infectious diseases
      • 3.6.1.2. Technological advancements in IVD
      • 3.6.1.3. Emergence of minimal invasive technologies
      • 3.6.1.4. Increasing government expenditures on healthcare
      • 3.6.1.5. Increase in popularity of personalized medicine approach
    • 3.6.2. Restraint
      • 3.6.2.1. Unclear reimbursement policies
      • 3.6.2.2. Stringent regulatory policies
    • 3.6.3. Opportunities
      • 3.6.3.1. Potential opportunities for outsourcing
      • 3.6.3.2. Convergence of new technologies
    • 3.6.4. Impact Analyses

CHAPTER 4: IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents
    • 4.2.1. Key market trends, growth factors, and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market analysis, by country
  • 4.3. Instruments
    • 4.3.1. Key market trends, growth factors, and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market analysis, by country
  • 4.4. Software & Services
    • 4.4.1. Key market trends, growth factors, and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market analysis, by country

CHAPTER 5: IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Immunodiagnostics
    • 5.2.1. Market size and forecast, by type
      • 5.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
      • 5.2.1.1.1. Market size and forecast
      • 5.2.1.1.2. Chemiluminescence Immunoassay (CLIA)
      • 5.2.1.1.2.1. Market size and forecast
      • 5.2.1.1.3. Fluorescence Immunoassay (FIA)
      • 5.2.1.1.3.1. Market size and forecast
      • 5.2.1.1.4. Colorimetric Immunoassay (CI)
      • 5.2.1.1.4.1. Market size and forecast
      • 5.2.1.2. Rapid Tests
      • 5.2.1.2.1. Market size and forecast
      • 5.2.1.3. Enzyme-Linked ImmunoSpot (ELISPOT)
      • 5.2.1.3.1. Market size and forecast
      • 5.2.1.4. Radioimmunoassay (RIA)
      • 5.2.1.4.1. Market size and forecast
      • 5.2.1.5. Western Blot
      • 5.2.1.5.1. Market size and forecast
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market analysis, by country
  • 5.3. Hematology
    • 5.3.1. Market size and forecast, by region
    • 5.3.2. Market share analysis, by country
  • 5.4. Molecular Diagnostics
    • 5.4.1. Market size and forecast, by type
      • 5.4.1.1. Polymerize Chain Reaction (PCR)
      • 5.4.1.1.1. Market size and forecast
      • 5.4.1.2. Isothermal Nucleic Acid Technology (INAAT)
      • 5.4.1.2.1. Market size and forecast
      • 5.4.1.3. Hybridization
      • 5.4.1.3.1. Market size and forecast
      • 5.4.1.4. DNA Diagnostics
      • 5.4.1.4.1. Market size and forecast
      • 5.4.1.5. Microarray
      • 5.4.1.5.1. Market size and forecast
      • 5.4.1.6. Others
      • 5.4.1.6.1. Market size and forecast
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis, by country
  • 5.5. Tissue Diagnostics
    • 5.5.1. Market size and forecast, by region
    • 5.5.2. Market share analysis, by country
  • 5.6. Clinical Chemistry
    • 5.6.1. Market size and forecast, by type
      • 5.6.1.1. Basic Metabolic Panel
      • 5.6.1.1.1. Market size and forecast
      • 5.6.1.2. Liver Panel
      • 5.6.1.2.1. Market size and forecast
      • 5.6.1.3. Renal Profile
      • 5.6.1.3.1. Market size and forecast
      • 5.6.1.4. Lipid Profile
      • 5.6.1.4.1. Market size and forecast
      • 5.6.1.5. Thyroid Function Panel
      • 5.6.1.5.1. Market size and forecast
      • 5.6.1.6. Electrolyte Panel
      • 5.6.1.6.1. Market size and forecast
      • 5.6.1.7. Specialty Chemicals
      • 5.6.1.7.1. Market size and forecast
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis, by country
  • 5.7. Others
    • 5.7.1. Market size and forecast, by region
    • 5.7.2. Market share analysis, by country

CHAPTER 6: IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Infectious Diseases
    • 6.2.1. Market size and forecast, by region
    • 6.2.2. Market share analysis
  • 6.3. Cancer
    • 6.3.1. Market size and forecast, by region
    • 6.3.2. Market share analysis, by country
  • 6.4. Cardiac Diseases
    • 6.4.1. Market size and forecast, by region
    • 6.4.2. Market share analysis, by country
  • 6.5. Immune System Disorders
    • 6.5.1. Market size and forecast, by region
    • 6.5.2. Market share analysis, by country
  • 6.6. Nephrological Diseases
    • 6.6.1. Market size and forecast, by region
    • 6.6.2. Market share analysis
  • 6.7. Gastrointestinal Diseases
    • 6.7.1. Market size and forecast, by region
    • 6.7.2. Market share analysis
  • 6.8. Others
    • 6.8.1. Market size and forecast, by region
    • 6.8.2. Market share analysis

CHAPTER 7: IN-VITRO DIAGNOSTICS MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Stand-Alone Laboratory
    • 7.2.1. Market size and forecast, by region
    • 7.2.2. Market share analysis, by country
  • 7.3. Hospitals
    • 7.3.1. Market size and forecast, by region
    • 7.3.2. Market share analysis, by country
  • 7.4. Academic & Medical Schools
    • 7.4.1. Market size and forecast, by region
    • 7.4.2. Market share analysis
  • 7.5. Point of Care Testing
    • 7.5.1. Market size and forecast, by region
    • 7.5.2. Market share analysis
  • 7.6. Others
    • 7.6.1. Market size and forecast, by region
    • 7.6.2. Market share analysis, by country

CHAPTER 8: IN-VITRO DIAGNOSTICS MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors, and opportunities
    • 8.2.2. Market size and forecast, by country
      • 8.2.2.1. U.S.
      • 8.2.2.1.1. U.S. In-vitro diagnostics market, by product type
      • 8.2.2.1.2. U.S. In-vitro diagnostics market, by technique
      • 8.2.2.1.3. U.S. In-vitro diagnostics market, by application
      • 8.2.2.1.4. U.S. In-vitro diagnostics market, by end user
      • 8.2.2.2. Canada
      • 8.2.2.2.1. Canada In-vitro diagnostics market, by product type
      • 8.2.2.2.2. Canada In-vitro diagnostics market, by technique
      • 8.2.2.2.3. Canada In-vitro diagnostics market, by application
      • 8.2.2.2.4. Canada In-vitro diagnostics market, by end user
      • 8.2.2.3. Mexico
      • 8.2.2.3.1. Mexico In-vitro diagnostics market, by product type
      • 8.2.2.3.2. Mexico In-vitro diagnostics market, by technique
      • 8.2.2.3.3. Mexico In-vitro diagnostics market, by application
      • 8.2.2.3.4. Mexico In-vitro diagnostics market, by end user
    • 8.2.3. Market size and forecast, by product type
    • 8.2.4. Market size and forecast, by technique
    • 8.2.5. Market size and forecast, by application
    • 8.2.6. Market size and forecast, by end user
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors, and opportunities
    • 8.3.2. Market size and forecast, by country
      • 8.3.2.1. Germany
      • 8.3.2.1.1. Germany In-vitro diagnostics market, by product type
      • 8.3.2.1.2. Germany In-vitro diagnostics market, by technique
      • 8.3.2.1.3. Germany In-vitro diagnostics market, by application
      • 8.3.2.1.4. Germany In-vitro diagnostics market, by end user
      • 8.3.2.2. France
      • 8.3.2.2.1. France In-vitro diagnostics market, by product type
      • 8.3.2.2.2. France In-vitro diagnostics market, by technique
      • 8.3.2.2.3. France In-vitro diagnostics market, by application
      • 8.3.2.2.4. France In-vitro diagnostics market, by end user
      • 8.3.2.3. UK
      • 8.3.2.3.1. UK In-vitro diagnostics market, by product type
      • 8.3.2.3.2. UK In-vitro diagnostics market, by technique
      • 8.3.2.3.3. UK In-vitro diagnostics market, by application
      • 8.3.2.3.4. UK In-vitro diagnostics market, by end user
      • 8.3.2.4. Italy
      • 8.3.2.4.1. Italy In-vitro diagnostics market, by product type
      • 8.3.2.4.2. Italy In-vitro diagnostics market, by technique
      • 8.3.2.4.3. Italy In-vitro diagnostics market, by application
      • 8.3.2.4.4. Italy In-vitro diagnostics market, by end user
      • 8.3.2.5. Spain
      • 8.3.2.5.1. Spain In-vitro diagnostics market, by product type
      • 8.3.2.5.2. Spain In-vitro diagnostics market, by technique
      • 8.3.2.5.3. Spain In-vitro diagnostics market, by application
      • 8.3.2.5.4. Spain In-vitro diagnostics market, by end user
      • 8.3.2.6. Rest of Europe
      • 8.3.2.6.1. Rest of Europe In-vitro diagnostics market, by product t type
      • 8.3.2.6.2. Rest of Europe In-vitro diagnostics market, by technique
      • 8.3.2.6.3. Rest of Europe In-vitro diagnostics market, by application
      • 8.3.2.6.4. Rest of Europe In-vitro diagnostics market, by end user
    • 8.3.3. Market size and forecast, by product type
    • 8.3.4. Market size and forecast, by technique
    • 8.3.5. Market size and forecast, by application
    • 8.3.6. Market size and forecast, by end user
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors, and opportunities
    • 8.4.2. Market size and forecast, by country
      • 8.4.2.1. Japan
      • 8.4.2.1.1. Japan In-vitro diagnostics market, by product type
      • 8.4.2.1.2. Japan In-vitro diagnostics market, by technique
      • 8.4.2.1.3. Japan In-vitro diagnostics market, by application
      • 8.4.2.1.4. Japan In-vitro diagnostics market, by end user
      • 8.4.2.2. China
      • 8.4.2.2.1. China In-vitro diagnostics market, by product type
      • 8.4.2.2.2. China In-vitro diagnostics market, by technique
      • 8.4.2.2.3. China In-vitro diagnostics market, by application
      • 8.4.2.2.4. China In-vitro diagnostics market, by end user
      • 8.4.2.3. Australia
      • 8.4.2.3.1. Australia In-vitro diagnostics market, by product type
      • 8.4.2.3.2. Australia In-vitro diagnostics market, by technique
      • 8.4.2.3.3. Australia In-vitro diagnostics market, by application
      • 8.4.2.3.4. Australia In-vitro diagnostics market, by end user
      • 8.4.2.4. India
      • 8.4.2.4.1. India In-vitro diagnostics market, by product type
      • 8.4.2.4.2. India In-vitro diagnostics market, by technique
      • 8.4.2.4.3. India In-vitro diagnostics market, by application
      • 8.4.2.4.4. India In-vitro diagnostics market, by end user
      • 8.4.2.5. South Korea
      • 8.4.2.5.1. South Korea In-vitro diagnostics market, by product type
      • 8.4.2.5.2. South Korea In-vitro diagnostics market, by technique
      • 8.4.2.5.3. South Korea In-vitro diagnostics market, by application
      • 8.4.2.5.4. South Korea In-vitro diagnostics market, by end user
      • 8.4.2.6. Rest of Asia-Pacific
      • 8.4.2.6.1. Rest of Asia-Pacific In-vitro diagnostics market, by product type
      • 8.4.2.6.2. Rest of Asia-Pacific In-vitro diagnostics market, by technique
      • 8.4.2.6.3. Rest of Asia-Pacific In-vitro diagnostics market, by application
      • 8.4.2.6.4. Rest of Asia-Pacific In-vitro diagnostics market, by end user
    • 8.4.3. Market size and forecast, by product type
    • 8.4.4. Market size and forecast, by technique
    • 8.4.5. Market size and forecast, by indication
    • 8.4.6. Market size and forecast, by end user
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors, and opportunities
    • 8.5.2. Market size and forecast, by country
      • 8.5.2.1. Brazil
      • 8.5.2.1.1. Brazil In-vitro diagnostics market, by product type
      • 8.5.2.1.2. Brazil In-vitro diagnostics market, by technique
      • 8.5.2.1.3. Brazil In-vitro diagnostics market, by application
      • 8.5.2.1.4. Brazil In-vitro diagnostics market, by end user
      • 8.5.2.2. Saudi Arabia
      • 8.5.2.2.1. Saudi Arabia In-vitro diagnostics market, by product type
      • 8.5.2.2.3. Saudi Arabia In-vitro diagnostics market, by technique
      • 8.5.2.2.4. Saudi Arabia In-vitro diagnostics market, by application
      • 8.5.2.2.5. Saudi Arabia In-vitro diagnostics market, by end user
      • 8.5.2.3. South Africa
      • 8.5.2.3.1. South Africa In-vitro diagnostics market, by product type
      • 8.5.2.3.2. South Africa In-vitro diagnostics market, by technique
      • 8.5.2.3.3. South Africa In-vitro diagnostics market, by application
      • 8.5.2.3.4. South Africa In-vitro diagnostics market, by end user
      • 8.5.2.4. Rest of LAMEA
      • 8.5.2.4.1. Rest of LAMEA In-vitro diagnostics market, by product type
      • 8.5.2.4.2. Rest of LAMEA In-vitro diagnostics market, by technique
      • 8.5.2.4.3. Rest of LAMEA In-vitro diagnostics market, by application
      • 8.5.2.4.4. Rest of LAMEA In-vitro diagnostics market, by end user
    • 8.5.3. Market size and forecast, by product type
    • 8.5.4. Market size and forecast, by technique
    • 8.5.5. Market size and forecast, by application
    • 8.5.6. Market size and forecast, by end user

CHAPTER 9: COMPANY PROFILES

  • 9.1. Abbott Laboratories
    • 9.1.1. Company overview
    • 9.1.2. Company snapshot
    • 9.1.3. Operating business segments
    • 9.1.4. Product type Portfolio
    • 9.1.5. Business performance
    • 9.1.6. Key strategic moves and developments
  • 9.2. Becton, Dickinson and Company
    • 9.2.1. Company overview
    • 9.2.2. Company snapshot
    • 9.2.3. Operating business segments
    • 9.2.4. Product type Portfolio
    • 9.2.5. Business performance
    • 9.2.6. Key strategic moves and developments
  • 9.3. bioMrieux SA
    • 9.3.1. Company overview
    • 9.3.2. Company snapshot
    • 9.3.3. Product type portfolio
    • 9.3.4. Business performance
    • 9.3.5. Key strategic moves and developments
  • 9.4. Bio-Rad Laboratories, Inc.
    • 9.4.1. Company overview
    • 9.4.2. Company snapshot
    • 9.4.3. Operating business segments
    • 9.4.4. Product type Portfolio
    • 9.4.5. Business performance
    • 9.4.6. Key strategic moves and developments
  • 9.5. Danaher Corporation (Beckman Coulter, Inc.)
    • 9.5.1. Company overview
    • 9.5.2. Company snapshot
    • 9.5.3. Operating business segments
    • 9.5.4. Product type portfolio
    • 9.5.5. Business performance
    • 9.5.6. Key strategic moves and developments
  • 9.6. F. Hoffmann-La Roche Ltd.
    • 9.6.1. Company overview
    • 9.6.2. Company snapshot
    • 9.6.3. Operating business segments
    • 9.6.4. Product type portfolio
    • 9.6.5. Business performance
    • 9.6.6. Key strategic moves and developments
  • 9.7. Johnson & Johnson
    • 9.7.1. Company overview
    • 9.7.2. Company snapshot
    • 9.7.3. Operating business segments
    • 9.7.4. Product type Portfolio
    • 9.7.5. Business performance
    • 9.7.6. Key strategic moves and developments
  • 9.8. QIAGEN N.V.
    • 9.8.1. Company overview
    • 9.8.2. Company snapshot
    • 9.8.3. Product type portfolio
    • 9.8.4. Business performance
  • 9.9. Sysmex Corporation
    • 9.9.1. Company overview
    • 9.9.2. Company snapshot
    • 9.9.3. Operating business segments
    • 9.9.4. Product type Portfolio
    • 9.9.5. Business performance
  • 9.10. Thermo Fisher Scientific, Inc.
    • 9.10.1. Company overview
    • 9.10.2. Company snapshot
    • 9.10.3. Operating business segments
    • 9.10.4. Product type Portfolio
    • 9.10.5. Business performance
    • 9.10.6. Key strategic moves and developments
Back to Top
전화 문의
F A Q